{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T14:51:27Z","timestamp":1774882287481,"version":"3.50.1"},"reference-count":53,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,12,1]],"date-time":"2015-12-01T00:00:00Z","timestamp":1448928000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,12,1]],"date-time":"2015-12-01T00:00:00Z","timestamp":1448928000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2015,8,13]],"date-time":"2015-08-13T00:00:00Z","timestamp":1439424000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Redox Biology"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1016\/j.redox.2015.08.012","type":"journal-article","created":{"date-parts":[[2015,8,14]],"date-time":"2015-08-14T02:04:32Z","timestamp":1439517872000},"page":"287-296","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":60,"special_numbering":"C","title":["NOSH-sulindac (AVT-18A) is a novel nitric oxide- and hydrogen sulfide-releasing hybrid that is gastrointestinal safe and has potent anti-inflammatory, analgesic, antipyretic, anti-platelet, and anti-cancer properties"],"prefix":"10.1016","volume":"6","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4060-7283","authenticated-orcid":false,"given":"Khosrow","family":"Kashfi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mitali","family":"Chattopadhyay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ravinder","family":"Kodela","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.redox.2015.08.012_bib1","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S1054-3589(08)57002-5","article-title":"Anti-inflammatory agents as cancer therapeutics","volume":"57","author":"Kashfi","year":"2009","journal-title":"Adv. Pharmacol."},{"key":"10.1016\/j.redox.2015.08.012_bib2","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1016\/S0140-6736(11)61720-0","article-title":"Short-term effects of daily aspirin on cancer incidence, mortality, and non-vascular death: analysis of the time course of risks and benefits in 51 randomised controlled trials","volume":"379","author":"Rothwell","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.redox.2015.08.012_bib3","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1056\/NEJMoa021735","article-title":"A randomized trial of aspirin to prevent colorectal adenomas","volume":"348","author":"Baron","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.redox.2015.08.012_bib4","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1056\/NEJMoa021633","article-title":"A randomized trial of aspirin to prevent colorectal adenomas in patients with previous colorectal cancer","volume":"348","author":"Sandler","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.redox.2015.08.012_bib5","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1093\/annonc\/mdu225","article-title":"Estimates of benefits and harms of prophylactic use of aspirin in the general population","volume":"26","author":"Cuzick","year":"2015","journal-title":"Ann. Oncol.: Off. J. Eur. Soc. Med. Oncol.\/ESMO"},{"key":"10.1016\/j.redox.2015.08.012_bib6","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1007\/s10549-015-3267-9","article-title":"Effect of COX-2 inhibitors and other non-steroidal inflammatory drugs on breast cancer risk: a meta-analysis","volume":"149","author":"de Pedro","year":"2015","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/j.redox.2015.08.012_bib7","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1097\/CEJ.0000000000000098","article-title":"Aspirin and NSAIDs for breast cancer chemoprevention","volume":"24","author":"Yiannakopoulou","year":"2014","journal-title":"Eur. J. Cancer Prev.: Off. J. Eur. Cancer Prev. Organ. (ECP)"},{"key":"10.1016\/j.redox.2015.08.012_bib8","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1093\/jnci\/djn324","article-title":"Breast cancer and use of nonsteroidal anti-inflammatory drugs: a meta-analysis","volume":"100","author":"Takkouche","year":"2008","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.redox.2015.08.012_bib9","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1097\/MPA.0b013e3182a8d41f","article-title":"High-dose aspirin consumption contributes to decreased risk for pancreatic cancer in a systematic review and meta-analysis","volume":"43","author":"Cui","year":"2014","journal-title":"Pancreas"},{"key":"10.1016\/j.redox.2015.08.012_bib10","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1158\/1940-6207.CAPR-13-0164","article-title":"Preventive effects of NSAIDs, NO-NSAIDs, and NSAIDs plus difluoromethylornithine in a chemically induced urinary bladder cancer model","volume":"7","author":"Nicastro","year":"2014","journal-title":"Cancer Prev. Res."},{"key":"10.1016\/j.redox.2015.08.012_bib11","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1093\/aje\/kwq437","article-title":"Nonsteroidal antiinflammatory drugs and bladder cancer: a pooled analysis","volume":"173","author":"Daugherty","year":"2011","journal-title":"Am. J. Epidemiol."},{"key":"10.1016\/j.redox.2015.08.012_bib12","doi-asserted-by":"crossref","DOI":"10.1002\/ijc.29601","article-title":"Non-steroidal anti-inflammatory drugs and the risk of head and neck cancer: a case-control analysis","author":"Becker","year":"2015","journal-title":"Int. J. Cancer J. Int. Cancer"},{"key":"10.1016\/j.redox.2015.08.012_bib13","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1111\/j.1442-2050.2011.01198.x","article-title":"Meta-analysis: non-steroidal anti-inflammatory drug use and the risk of esophageal squamous cell carcinoma","volume":"24","author":"Sun","year":"2011","journal-title":"Dis. Esophagus: Off. J. Int. Soc. Dis. Esophagus\/ISDE"},{"key":"10.1016\/j.redox.2015.08.012_bib14","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1093\/annonc\/mdu578","article-title":"Low-dose aspirin use and the risk of ovarian cancer in Denmark","volume":"26","author":"Baandrup","year":"2015","journal-title":"Ann. Oncol.: Off. J. Eur. Soc. Med. Oncol.\/ESMO"},{"key":"10.1016\/j.redox.2015.08.012_bib15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/jnci\/djt431","article-title":"Aspirin, nonaspirin nonsteroidal anti-inflammatory drug, and acetaminophen use and risk of invasive epithelial ovarian cancer: a pooled analysis in the Ovarian Cancer Association Consortium","volume":"106","author":"Trabert","year":"2014","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.redox.2015.08.012_bib16","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1038\/bjc.2012.227","article-title":"Aspirin but not ibuprofen use is associated with reduced risk of prostate cancer: a PLCO study","volume":"107","author":"Shebl","year":"2012","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.redox.2015.08.012_bib17","doi-asserted-by":"crossref","first-page":"1808","DOI":"10.1093\/jnci\/djs452","article-title":"Nonsteroidal anti-inflammatory drug use, chronic liver disease, and hepatocellular carcinoma","volume":"104","author":"Sahasrabuddhe","year":"2012","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.redox.2015.08.012_bib18","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1002\/pds.1718","article-title":"Effect of non-steroidal anti-inflammatory drugs on non-melanoma skin cancer incidence in the SKICAP-AK trial","volume":"18","author":"Clouser","year":"2009","journal-title":"Pharmacoepidemiol. Drug Saf."},{"key":"10.1016\/j.redox.2015.08.012_bib19","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1093\/jnci\/djq442","article-title":"Chemoprevention of nonmelanoma skin cancer with celecoxib: a randomized, double-blind, placebo-controlled trial","volume":"102","author":"Elmets","year":"2010","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.redox.2015.08.012_bib20","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1158\/1940-6207.CAPR-14-0018","article-title":"Aspirin and other NSAIDs as chemoprevention agents in melanoma","volume":"7","author":"Goodman","year":"2014","journal-title":"Cancer Prev. Res."},{"key":"10.1016\/j.redox.2015.08.012_bib21","doi-asserted-by":"crossref","first-page":"1992","DOI":"10.1016\/S0016-5085(97)99999-6","article-title":"Nonsteroidal anti-inflammatory drugs and colorectal cancer: evolving concepts of their chemopreventive actions","volume":"113","author":"Shiff","year":"1997","journal-title":"Gastroenterology"},{"key":"10.1016\/j.redox.2015.08.012_bib22","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1126\/science.1651562","article-title":"Identification of FAP locus genes from chromosome 5q21","volume":"253","author":"Kinzler","year":"1991","journal-title":"Science"},{"key":"10.1016\/j.redox.2015.08.012_bib23","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1136\/gut.2007.136127","article-title":"Guidelines for the clinical management of familial adenomatous polyposis (FAP)","volume":"57","author":"Vasen","year":"2008","journal-title":"Gut"},{"key":"10.1016\/j.redox.2015.08.012_bib24","series-title":"Goodman & Gilman's Pharmacological Basis of Therapeutics","first-page":"959","article-title":"Anti-inflammatory, Antipyretic, and Analgesic Agents; Pharmacology of Gout","author":"Grosser","year":"2012"},{"key":"10.1016\/j.redox.2015.08.012_bib25","doi-asserted-by":"crossref","first-page":"201","DOI":"10.3393\/ac.2014.30.4.201","article-title":"Regression of colonic adenomas after treatment with sulindac in familial adenomatous polyposis: a case with a 2-year follow-up without a prophylactic colectomy","volume":"30","author":"Kim","year":"2014","journal-title":"Ann. Coloproctol."},{"key":"10.1016\/j.redox.2015.08.012_bib26","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1111\/j.1440-1746.2006.04181.x","article-title":"Effect of the non-steroidal anti-inflammatory drug sulindac on colorectal adenomas of uncolectomized familial adenomatous polyposis","volume":"21","author":"Matsumoto","year":"2006","journal-title":"J. Gastroenterol. Hepatol."},{"key":"10.1016\/j.redox.2015.08.012_bib27","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1002\/jso.2930240119","article-title":"Sulindac for polyposis of the colon","volume":"24","author":"Waddell","year":"1983","journal-title":"J. Surg. Oncol."},{"key":"10.1016\/j.redox.2015.08.012_bib28","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1056\/NEJM199305063281805","article-title":"Treatment of colonic and rectal adenomas with sulindac in familial adenomatous polyposis","volume":"328","author":"Giardiello","year":"1993","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.redox.2015.08.012_bib29","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1039\/c3md00185g","article-title":"Synthesis and biological activity of NOSH-naproxen (AVT-219) and NOSH-sulindac (AVT-18A) as potent anti-inflammatory agents with chemotherapeutic potential","volume":"4","author":"Kodela","year":"2013","journal-title":"Med. Chem. Commun."},{"key":"10.1016\/j.redox.2015.08.012_bib30","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1053\/gast.2000.9304","article-title":"Nitric oxide in mucosal defense: a little goes a long way","volume":"119","author":"Wallace","year":"2000","journal-title":"Gastroenterology"},{"key":"10.1016\/j.redox.2015.08.012_bib31","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.gtc.2009.03.001","article-title":"Prevention of nonsteroidal anti-inflammatory drug-induced ulcer: looking to the future","volume":"38","author":"Fiorucci","year":"2009","journal-title":"Gastroenterol. Clin. N. Am."},{"key":"10.1016\/j.redox.2015.08.012_bib32","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1111\/j.1476-5381.1984.tb16447.x","article-title":"The anti-ulcerogenic activity of the unripe plantain banana (Musa species)","volume":"82","author":"Best","year":"1984","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.redox.2015.08.012_bib33","first-page":"502","article-title":"Antiinflammatory, analgesis and antipyretic effects of glaucine in rats and mice","volume":"4","author":"Pinto","year":"1998","journal-title":"Pharm. Pharmacol. Commun."},{"key":"10.1016\/j.redox.2015.08.012_bib34","doi-asserted-by":"crossref","first-page":"544","DOI":"10.3181\/00379727-111-27849","article-title":"Carrageenan-induced edema in hind paw of the rat as an assay for antiinflammatory drugs","volume":"111","author":"Winter","year":"1962","journal-title":"Proc. Soc. Exp. Biol. Med."},{"key":"10.1016\/j.redox.2015.08.012_bib35","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1182\/blood-2002-12-3882","article-title":"Platelet-collagen interaction: is GPVI the central receptor?","volume":"102","author":"Nieswandt","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.redox.2015.08.012_bib36","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/0090-6980(83)90025-4","article-title":"Requirements for hydroperoxide by the cyclooxygenase and peroxidase activities of prostaglandin H synthase","volume":"25","author":"Kulmacz","year":"1983","journal-title":"Prostaglandins"},{"key":"10.1016\/j.redox.2015.08.012_bib37","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/j.bcp.2011.12.019","article-title":"Hydrogen sulfide-releasing aspirin suppresses NF-kappaB signaling in estrogen receptor negative breast cancer cells in vitro and in vivo","volume":"83","author":"Chattopadhyay","year":"2012","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.redox.2015.08.012_bib38","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1139\/y97-130","article-title":"Comparison of the cyclooxygenase-1 inhibitory properties of nonsteroidal anti-inflammatory drugs (NSAIDs) and selective COX-2 inhibitors, using sensitive microsomal and platelet assays","volume":"75","author":"Riendeau","year":"1997","journal-title":"Can. J. Physiol. Pharmacol."},{"key":"10.1016\/j.redox.2015.08.012_bib39","first-page":"1","article-title":"NOSH-aspirin (NBS-1120), a dual nitric oxide and hydrogen sulfide-releasing hybrid, reduces inflammatory pain","volume":"3","author":"Fonesca","year":"2015","journal-title":"Pharmacol. Res. Perspect."},{"key":"10.1016\/j.redox.2015.08.012_bib40","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1586\/ecp.10.134","article-title":"Hydrogen sulfide and inflammation: the good, the bad, the ugly and the promising","volume":"4","author":"Whiteman","year":"2011","journal-title":"Expert Rev. Clin. Pharmacol."},{"key":"10.1016\/j.redox.2015.08.012_bib41","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1248\/bpb.b13-00018","article-title":"Inhibition by hydrogen sulfide of rabbit platelet aggregation and calcium mobilization","volume":"36","author":"Nishikawa","year":"2013","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.redox.2015.08.012_bib42","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.cbi.2014.06.001","article-title":"The possible role of hydrogen sulfide as a modulator of hemostatic parameters of plasma","volume":"220","author":"Olas","year":"2014","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.redox.2015.08.012_bib43","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0083-6729(08)60639-1","article-title":"Nitric oxide and platelet aggregation","volume":"57","author":"Riddell","year":"1999","journal-title":"Vitam. Horm."},{"key":"10.1016\/j.redox.2015.08.012_bib44","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/0006-2952(96)00181-5","article-title":"Effects of nonsteroidal anti-inflammatory drugs on proliferation and on induction of apoptosis in colon cancer cells by a prostaglandin-independent pathway","volume":"52","author":"Hanif","year":"1996","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.redox.2015.08.012_bib45","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1124\/jpet.102.042754","article-title":"Nitric oxide-donating nonsteroidal anti-inflammatory drugs inhibit the growth of various cultured human cancer cells: evidence of a tissue type-independent effect","volume":"303","author":"Kashfi","year":"2002","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.redox.2015.08.012_bib46","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.bbrc.2012.02.051","article-title":"NOSH-aspirin (NBS-1120), a novel nitric oxide- and hydrogen sulfide-releasing hybrid is a potent inhibitor of colon cancer cell growth in vitro and in a xenograft mouse model","volume":"419","author":"Chattopadhyay","year":"2012","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.redox.2015.08.012_bib47","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.niox.2014.12.009","article-title":"On the chemical biology of the nitrite\/sulfide interaction","volume":"46","author":"Cortese-Krott","year":"2015","journal-title":"Nitric Oxide: Biol. Chem.\/Off. J. Nitric Oxide Soc."},{"key":"10.1016\/j.redox.2015.08.012_bib48","doi-asserted-by":"crossref","first-page":"12016","DOI":"10.1021\/ja3009693","article-title":"Chemical characterization of the smallest S-nitrosothiol, HSNO; cellular cross-talk of H2S and S-nitrosothiols","volume":"134","author":"Filipovic","year":"2012","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.redox.2015.08.012_bib49","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.1509277112","article-title":"Key bioactive reaction products of the NO\/H2S interaction are S\/N-hybrid species, polysulfides, and nitroxyl","author":"Cortese-Krott","year":"2015","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.redox.2015.08.012_bib50","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1158\/1535-7163.MCT-05-0260","article-title":"The sulindac derivatives OSI-461, OSIP486823, and OSIP487703 arrest colon cancer cells in mitosis by causing microtubule depolymerization","volume":"5","author":"Xiao","year":"2006","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.redox.2015.08.012_bib51","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1038\/nrd794","article-title":"Potential cardioprotective actions of no-releasing aspirin","volume":"1","author":"Wallace","year":"2002","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.redox.2015.08.012_bib52","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.clpt.2005.01.011","article-title":"Renal effects of the cyclooxygenase-inhibiting nitric oxide donator AZD3582 compared with rofecoxib and naproxen during normal and low sodium intake","volume":"77","author":"Huledal","year":"2005","journal-title":"Clin. Pharmacol. Therap."},{"key":"10.1016\/j.redox.2015.08.012_bib53","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.ejphar.2010.08.039","article-title":"Activity of a new hydrogen sulfide-releasing aspirin (ACS14) on pathological cardiovascular alterations induced by glutathione depletion in rats","volume":"648","author":"Rossoni","year":"2010","journal-title":"Eur. J. Pharmacol."}],"container-title":["Redox Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213231715001020?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213231715001020?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T05:54:33Z","timestamp":1761976473000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213231715001020"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,12]]},"references-count":53,"alternative-id":["S2213231715001020"],"URL":"https:\/\/doi.org\/10.1016\/j.redox.2015.08.012","relation":{},"ISSN":["2213-2317"],"issn-type":[{"value":"2213-2317","type":"print"}],"subject":[],"published":{"date-parts":[[2015,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"NOSH-sulindac (AVT-18A) is a novel nitric oxide- and hydrogen sulfide-releasing hybrid that is gastrointestinal safe and has potent anti-inflammatory, analgesic, antipyretic, anti-platelet, and anti-cancer properties","name":"articletitle","label":"Article Title"},{"value":"Redox Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.redox.2015.08.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}